Home Cart Sign in  
Chemical Structure| 582315-72-8 Chemical Structure| 582315-72-8

Structure of BMS-265246
CAS No.: 582315-72-8

Chemical Structure| 582315-72-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2/cyclin E with IC50 of 6 and 9 nM respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-265246

CAS No. :582315-72-8
Formula : C18H17F2N3O2
M.W : 345.34
SMILES Code : O=C(C1=CN=C(NN=C2)C2=C1OCCCC)C3=C(F)C=C(C)C=C3F
MDL No. :MFCD22420825
InChI Key :SCFMWQIQBVZOQR-UHFFFAOYSA-N
Pubchem ID :135402864

Safety of BMS-265246

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of BMS-265246

Hedgehog

Isoform Comparison

Biological Activity

Target
  • CDK4

    CDK4/CyclinD, IC50:230 nM

  • CDK2

    CDK2/CyclinE, IC50:9 nM

  • CDK1

    CDK1/CyclinB, IC50:6 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 1 μM 24 h To investigate the effect of BMS-265246 on lamin A/C status in Nestin-knockdown cells, results showed that BMS-265246 did not alter the disassembly status of lamin A/C PMC6127343
L1210 cells 400 nM Partially inhibit CDK1 activity to examine changes in the TMRE signal during STLC-mediated prometaphase arrest. Results showed that partial inhibition of CDK1 reduces the extent of mitotic mitochondrial hyperpolarization. PMC7536222

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.90mL

0.58mL

0.29mL

14.48mL

2.90mL

1.45mL

28.96mL

5.79mL

2.90mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories